CicloMed Announces First Patient Dosed with Ciclopirox Prodrug in Phase I Trial in Patients with Advanced Solid Tumors
February 28, 2018 10:08 ET
|
CicloMed LLC
KANSAS CITY, Mo., Feb. 28, 2018 (GLOBE NEWSWIRE) -- CicloMed LLC, a biotechnology company developing novel treatments for bladder cancer, today announced that the first patient has been dosed in a...
Lifeline Biotechnologies Provides Information to the Public and its Shareholders
February 28, 2018 08:30 ET
|
Lifeline Biotechnologies
Reno, NV , Feb. 28, 2018 (GLOBE NEWSWIRE) --
Lifeline Biotechnologies, Inc, (“The Company”) (OTC PINK: LLBO) Provides Information to the Public and Updates It’s Shareholders. In 2017...
Immunotech Laboratories, Inc. Enters Negotiations to Engage a Quality Person (QP) for Receipt and Distribution of Treatment in Europe
February 27, 2018 13:00 ET
|
Immunotech Laboratories, Inc.
MONROVIA, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Immunotech Laboratories, Inc. (OTC Markets "ECPO", “Immunotech” or the “Company”) announced today that negotiations have begun with one of the World’s...
Wave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System Disorders
February 20, 2018 07:00 ET
|
Wave Life Sciences
Wave to receive at least $230 million, including $110 million in upfront cash, $60 million in equity investment and at least $60 million in research support Takeda to receive option to co-develop...
drchrono Announces Partnership with HDP Health Enabling Physicians and Patients Access to Clinical Trials
January 31, 2018 11:00 ET
|
drchrono Inc.
SUNNYVALE, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- drchrono Inc., the company enabling the medical practice of the future, today announced that it has partnered with HDP Health to provide...
Veritas’ Research Arm Cannevert Signs Clinical Research Agreement for Human Studies to Assess its Lead Cannabis Strain for Pain
January 10, 2018 17:02 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that its research arm,...
Inspire and Antidote Launch End-to-End Clinical Trial Recruitment Solution to Accelerate Medical Research
January 04, 2018 07:00 ET
|
Inspire
ARLINGTON, Va. and NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Inspire, the leading healthcare social network, and Antidote, a digital health company that connects patients with research, announced...
Medable Inc. to Present at the Biotech Showcase Annual Conference on January 10, 2018
January 03, 2018 10:00 ET
|
Medable
PALO ALTO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Medable Inc., the leading app and analytics platform for healthcare, today announced that Medable CEO Dr. Michelle Longmire will talk about “The...
Endonovo Therapeutics Acquires Assets of Electroceuticals Developer, Rio Grande Neurosciences, and Settles Lawsuit
December 26, 2017 07:30 ET
|
Endonovo Therapeutics, Inc.
Endonovo to Fund All Currently Planned and Future Clinical Trials for Traumatic Brain Injury, Post-Concussion Syndrome, Stroke and Other Central Nervous System Disorders LOS ANGELES, CA, Dec. ...
Stephanie Finnegan joins Cromos™ Pharma as Chief Operating Officer, company looks to expand its North American footprint
December 11, 2017 18:10 ET
|
Cromos Pharma
PORTLAND, Ore., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Cromos™ Pharma, a premier regional contract research organization announced today that Stephanie Finnegan has been appointed as its Chief Operating...